(Q39177294)

9 September 2017

title

Defining peripheral nervous system dysfunction in the SOD-1G93A transgenic rat model of amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

9 September 2017

main subject

0 references

author

Linda Chaabane

2

0 references

Caterina Bendotti

14

0 references

Nilo Riva

1

0 references

Teuta Domi

object named as

Teuta Domi

5

0 references

Angelo Quattrini

object named as

Angelo Quattrini

15

0 references

Giancarlo Comi

13

object named as

Giancarlo Comi

1 reference

9 September 2017

Marco Peviani

3

1 reference

9 September 2017

Daniela Ungaro

4

1 reference

9 September 2017

Giorgia Dina

6

1 reference

9 September 2017

Francesca Bianchi

7

1 reference

9 September 2017

Giorgia Spano

8

1 reference

9 September 2017

Federica Cerri

9

1 reference

9 September 2017

Paola Podini

10

1 reference

9 September 2017

Massimo Corbo

11

1 reference

9 September 2017

Ubaldo Del Carro

12

1 reference

9 September 2017

language of work or name

1 reference

1 July 2014

1 reference

Journal of Neuropathology & Experimental Neurology

9 September 2017

published in

1 reference

9 September 2017

volume

73

1 reference

9 September 2017

issue

7

1 reference

9 September 2017

page(s)

658-670

1 reference

Amyotrophic lateral sclerosis

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

The epidemiology of motor neuron diseases: a review of recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Axon pathology in neurological disease: a neglected therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Axonal degeneration in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Disease progression of human SOD1 (G93A) transgenic ALS model rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

The brachial plexus branches to the pectoral muscles in adult rats: morphological aspects and morphometric normative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Amyotrophic lateral sclerosis: a neurovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

In vivo assessment of peripheral nerve regeneration by diffusion tensor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Electrophysiological analysis of a murine model of motoneuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Chapter 6: Methods and protocols in peripheral nerve regeneration experimental research: part III-electrophysiological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

The onset of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Role of axonal transport in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Axonal mitochondrial clusters containing mutant SOD1 in transgenic models of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Deficits in axonal transport precede ALS symptoms in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

The "dying-back" phenomenon of motor neurons in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Concepts for regulation of axon integrity by enwrapping glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

The Role of immune and inflammatory mechanisms in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Inflammation in ALS and SMA: sorting out the good from the evil

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Inflammation and neurovascular changes in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Microglia in ALS: the good, the bad, and the resting

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1G93A-induced motor neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Motor nerve biopsy: Clinical usefulness and histopathological criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Chronic motor axonal neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000081

10.1097/NEN.0000000000000081

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference